Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

Published 2013 View Full Article

Authors

Keywords

Journal

LANCET ONCOLOGY

Volume 15, Issue 1, Pages 78-86

Publisher

Elsevier BV

Online

2013-12-10

DOI

10.1016/s1470-2045(13)70549-7

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

LANCET ONCOLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Add your recorded webinar